Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Homatropine hydrobromide 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 2% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 2% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine hydrobromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 10 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 10 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 20 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 20 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Product containing precisely homatropine hydrobromide 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Product containing precisely homatropine hydrobromide 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 50 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 50 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 2.5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Homatropine hydrobromide 2.5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine hydrobromide |
Inferred relationship |
Some |
1 |